Donor Lymphocyte Infusion in Myeloid Malignancies: Reassessing Predictors of Response

Puntos clave

• Response to donor lymphocyte infusion varies based on specific predictors observed in myeloid malignancies.
• Key findings reveal that certain factors significantly correlate with treatment effectiveness, guiding future interventions.
• Analysis of clinical data highlights the role of immunotherapy in enhancing responses after donor lymphocyte infusion.
• These insights may enable personalized approaches in treating myeloid malignancies, optimizing donor lymphocyte use.